GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Taiwan Advanced Nanotech Inc (ROCO:6797) » Definitions » ROC (Joel Greenblatt) %

Taiwan Advanced Nanotech (ROCO:6797) ROC (Joel Greenblatt) % : -26.33% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Taiwan Advanced Nanotech ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Taiwan Advanced Nanotech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -26.33%.

The historical rank and industry rank for Taiwan Advanced Nanotech's ROC (Joel Greenblatt) % or its related term are showing as below:

ROCO:6797' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -61.71   Med: -19.56   Max: 284.93
Current: -32.95

During the past 8 years, Taiwan Advanced Nanotech's highest ROC (Joel Greenblatt) % was 284.93%. The lowest was -61.71%. And the median was -19.56%.

ROCO:6797's ROC (Joel Greenblatt) % is ranked worse than
63.73% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 1.605 vs ROCO:6797: -32.95

Taiwan Advanced Nanotech's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Taiwan Advanced Nanotech ROC (Joel Greenblatt) % Historical Data

The historical data trend for Taiwan Advanced Nanotech's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Advanced Nanotech ROC (Joel Greenblatt) % Chart

Taiwan Advanced Nanotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 284.93 140.42 70.14 -33.49 -28.22

Taiwan Advanced Nanotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.58 -30.16 -34.64 -30.52 -26.33

Competitive Comparison of Taiwan Advanced Nanotech's ROC (Joel Greenblatt) %

For the Medical Devices subindustry, Taiwan Advanced Nanotech's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Advanced Nanotech's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Taiwan Advanced Nanotech's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Taiwan Advanced Nanotech's ROC (Joel Greenblatt) % falls into.


;
;

Taiwan Advanced Nanotech ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(23.087 + 280.68 + 16.676) - (52.283 + 0 + 7.07)
=261.09

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(24.533 + 252.675 + 17.496) - (48.135 + 0 + 6.958)
=239.611

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Taiwan Advanced Nanotech for the quarter that ended in Dec. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-164.206/( ( (390.706 + max(261.09, 0)) + (355.668 + max(239.611, 0)) )/ 2 )
=-164.206/( ( 651.796 + 595.279 )/ 2 )
=-164.206/623.5375
=-26.33 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Advanced Nanotech  (ROCO:6797) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Taiwan Advanced Nanotech ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Taiwan Advanced Nanotech's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Advanced Nanotech Business Description

Traded in Other Exchanges
N/A
Address
No. 188, Wenhe Road, 6th Floor, Leshan Lane, Guishan District, Taoyuan City, TWN, 330
Taiwan Advanced Nanotech Inc is engaged in development and manufacturing of various functional nanoparticles and automated nucleic acid extraction machines and trading related businesses. With expertise in automation, buffer optimization and modification of magnetic beads, it focuses on offering customer convenient and practical solutions to advance research, life science and molecular diagnostics. It offers various products to meet the requirements of customers. The company's products include Automated Extraction Instruments; Reagent Kit; Mag Nanoparticles; and Consumables.

Taiwan Advanced Nanotech Headlines

No Headlines